1 / 9

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than that of the API over the same period. In 2013, China chemical drug preparation industry and and China API industry recorded revenue of RMB 573.1 billion and RMB 382 billion, with gross margin of 35%-40% and 20%, respectively. To Read Complete Report with Toc: http://www.marketresearchreports.biz/analysis/206780

Mrrbizreports
Download Presentation

China Chemical Pharmaceutical Industry Report, 2013-2016

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ChinaChemicalPharmaceuticalIndustryReport,2013-2016 Chemicalpharmaceuticalconsistsmainlyofchemicaldrug preparationandactivepharmaceuticalingredient(API),andthegrossmarginofchemicaldrugpreparationindustryisgenerallyhigherthanthatoftheAPIoverthesameperiod.In2013,ChinachemicaldrugpreparationindustryandandChinaAPIindustry

  2. recordedrevenueofRMB573.1billionandRMB382billion,with grossmarginof35%-40%and20%,respectively. ToReadCompleteReportwithToc: http://www.marketresearchreports.biz/analysis/206780 ChinaisabigproducerofchemicalAPIs,capableofproducing about1,600varietiesofAPIs.ChinaranksfirstworldwideinoutputofseveralbulkAPIsincludingpenicillins,vitaminsandantipyreticanalgesics,andholdsasignificantshareofthefeaturedAPIslikestatins,prils,sartansintheworld.Chinaproduced2.709milliontonsofchemicalAPIsin2013.

  3. AlthoughChinaistheworld'sleadingchemicalAPIssupplyregion, theconcentrationofChinachemicalAPIsindustryisratherlowduetonumerouscategoriesofAPIsandlimitedoverallstrengthofdomesticenterprises,whichoccupyanimportantplaceonlyinsingleorafewcategoriesofpharmaceuticalsmarket.Inaddition,underthepressureofbothenvironmentalprotectionandindustrialupgrading,manylargeAPIscompaniesinthecountryaretransformingintodrugpreparationcompaniesthroughmeanssuchasR&Dandacquisitions. BrowseFullReportWithToc: http://www.marketresearchreports.biz/analysis-details/china-chemical-pharmaceutical-industry-report-2013-2016

  4. NorthChinaPharmaceuticalGroupCorp.(NCPC)andNortheast PharmaceuticalGroupCo.,Ltd.aremajorsuppliersofantibiotic andVCAPIsinChina,withsupplyofVSreachingaround20,000 tonseach.In2013,thetwocompanies’totalrevenuefromAPIs andtheirrevenuefromdrugpreparationbusinessreachedRMB 5.695billionandRMB3.871billion,respectively. ZhejiangMedicineCo.,Ltd.andZhejiangNHUCo.,Ltd.arethe leadingmanufacturersofVEproductsaroundtheglobe, materials(vitalingredientsfortheproductionofVEarerawmaterials:isophytolandtrimethylhydroquinone)forproducedbythemselves.However,thetwocompanies’ withraw limited VEbeing developmentisconstrainedduetoaweakglobaldemandforVE, ofwhichZhejiangMedicinereportedrevenueofRMB4.915billion

  5. frompharmaceuticalbusiness(APIs+preparation),down6.3%year onyear. ClickHereToDownloadDetailReport: http://www.marketresearchreports.biz/sample/sample/206780 ZhejiangHisunPharmaceuticalCo.,Ltd.andZhejiangHuahai PharmaceuticalsCo.,Ltd.arethekeysuppliersoffeaturedAPIsinChina,ofwhichtheformerspecializesinantineoplasticandcardiovascularproducts,andthelatter,whichobtainsthreecertificatesfromEDQMin2013,isamajorglobalsupplierofprilsandsartansAPIs.In2013,thetwocompanies’totalrevenuesfromAPIsanddrugpreparationbusinesswereRMB3.226billionand

  6. RMB2.272billion,risingby19.5%and14.7%fromtheprevious year,respectively. ZhejiangHisunPharmaceuticalCo.,Ltd.andZhejiangHuahai PharmaceuticalsCo.,Ltd.arethekeysuppliersoffeaturedAPIsinChina,ofwhichtheformerspecializesinantineoplasticandcardiovascularproducts,andthelatter,whichobtainsthreecertificatesfromEDQMin2013,isamajorglobalsupplierofprilsandsartansAPIs.In2013,thetwocompanies’totalrevenuesfromAPIsanddrugpreparationbusinesswereRMB3.226billionandRMB2.272billion,risingby19.5%and14.7%fromthepreviousyear,respectively.

  7. ZhejiangXianjuPharmaceuticalCo.,Ltd.andTianjinTianyao PharmaceuticalsCo.,Ltd.aretheleadingsuppliersofhormone APIs,ofwhichtheformerhasbeenaggressivelyexpandinginto downstreamdrugpreparationbusiness.Inthecontextofstricter environmentalstandardsandrisingcostsofrawmaterials, developingthedownstreamwillundoubtedlyensure competitivenessofthecompany.In2013,XianjuPharmaceutical postedtotalrevenueofRMB2.233billionfromAPIsand preparationbusiness,up16.2%againsttheprioryear.Alsoin 2013,thecompanyacquiredthreeEDQMcertificatesforitsAPIs.

  8. AboutUs Marketresearchreports.bizisthemostcomprehensivecollectionof marketresearchreports.Marketresearchreports.bizservicesareespeciallydesignedtosavetimeandmoneyofourclients.Weareaonestopsolutionforallyourresearchneeds,ourmainofferingsaresyndicatedresearchreports,customresearch,subscriptionaccessandconsultingservices.Weserveallsizesandtypesofcompaniesspanningacrossvariousindustries

  9. ContactUS: Office:UnitedStates StateTower 90StateStreet,Suite700 Albany,NY12207 UnitedStates TollFree:866-997-4948 Tel:+1-518-618-1030 E:sales@marketresearchreports.biz

More Related